Think Research Announces Date of First Quarter 2023 Results and Conference Call Details

Earnings To Be Announced After Market Close on Monday May 29th, 2023

TORONTO, May 24, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, announced today that it will release First Quarter Results after-market, Monday, May 29th, 2023. Think's financial statements and Management Discussion and Analysis will be available under the Company's profile on SEDAR and on the Company's website as of 5:15 p.m. Eastern Time. Prior to market open on Tuesday May 30^th, at 8:30 a.m., CEO Sachin Aggarwal and CFO John Hayes with host a conference call to discuss the results, with a Q&A session to follow.

TIME: 8:30AM EST, Tuesday May 30th, 2023

Conference Call Participant Details: To join the conference call without operator assistance, you may register and enter your phone number HERE to receive an instant automated call back. Participants can also dial direct to be entered to the call by an Operator: 

Toronto: 416-764-8659

North American Toll Free: 1-888-664-6392

Webinar URL: https://app.webinar.net/qBYZ3lEXxMG

Conference Replay

Local: 416-764-8677

North American Toll Free: 1-888-390-0541

Replay Entry Code: 318592 #

Expiration Date: 06/06/2023

About Think Research Corporation

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process and standardize care, to facilitate better health care outcomes. The Company gathers, develops, and delivers knowledge-based solutions globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and / or governments. The Company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies, including acquired companies.

Think licenses its solutions to over 14,200 facilities for over 320,000 primary care, acute care, and long-term care doctors, nurses and pharmacists that rely on the content and data provided by Think to support their practices.  Over 3 million patients and residents annually receive better care due to the essential data that Think produces, manages and delivers.

In addition, the Company collects and manages pharmaceutical and clinical trial data via the BioPharma Services entity that Think acquired on September 10, 2021.  BioPharma Services is a leading provider of bioequivalence and Phase 1 clinical research services to pharmaceutical companies globally. Think's other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery. Visit: www.thinkresearch.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information: https://www.thinkresearch.com/ca/investors/

SOURCE Think Research Corporation

Mark Sakamoto, Executive Vice President, Think Research, 416.388.7119, [email protected]